A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Primary Breast Cancer

NCT02005549 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: bevacizumab [Avastin]
DRUG: docetaxel
DRUG: capecitabine [Xeloda]

Sponsor

Hoffmann-La Roche